HMGB1 and neoplasm: These approaches are expected to further contextualize the molecular insights regarding the HMGB1/ZNF460/BECN1 axis within the broader “tumor ecosystem” framework, thereby offering a more comprehensive strategy to address radiotherapy resistance in CRC.